Liu J - Search Results

1

The effect of PD-L1/PD-1 immunotherapy in the treatment of squamous non-small-cell lung cancer: a meta-analysis of randomized controlled clinical trials.

Li S, Zhang S, Liu J, Yang C, Zhang L, Cheng Y. Li S, et al. Among authors: liu j. J Thorac Dis. 2019 Nov;11(11):4453-4463. doi: 10.21037/jtd.2019.11.12. J Thorac Dis. 2019. PMID: 31903233 Free PMC article.

2

Current and future drug combination strategies based on programmed death-1/programmed death-ligand 1 inhibitors in non-small cell lung cancer.

Cheng Y, Li H, Zhang L, Liu JJ, Yang CL, Zhang S. Cheng Y, et al. Chin Med J (Engl). 2021 Jun 16;134(15):1780-1788. doi: 10.1097/CM9.0000000000001560. Chin Med J (Engl). 2021. PMID: 34133356 Free PMC article. Review.

3

Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.

Liu J, Li S, Zhang S, Liu Y, Ma L, Zhu J, Xin Y, Wang Y, Yang C, Cheng Y. Liu J, et al. Among authors: liu y. J Clin Lab Anal. 2019 Oct;33(8):e22964. doi: 10.1002/jcla.22964. Epub 2019 Jul 8. J Clin Lab Anal. 2019. PMID: 31282096 Free PMC article.

4

Zhang L, Bai L, Liu X, Liu Y, Li S, Liu J, Zhang S, Yang C, Ren X, Cheng Y. Zhang L, et al. Among authors: liu j, liu y, liu x. Thorac Cancer. 2020 May;11(5):1170-1179. doi: 10.1111/1759-7714.13370. Epub 2020 Mar 5. Thorac Cancer. 2020. PMID: 32134200 Free PMC article.

5

Pretreatment prognostic nutritional index is a prognostic marker for extensive-stage small cell lung cancer patients treated with anlotinib.

Liu J, Li S, Zhang S, Yang C, Zhang L, Zhang B, Cheng Y, Wang C. Liu J, et al. J Thorac Dis. 2020 Oct;12(10):5765-5773. doi: 10.21037/jtd-20-755. J Thorac Dis. 2020. PMID: 33209408 Free PMC article.

6

Circulating tumor cell counts/change for outcome prediction in patients with extensive-stage small-cell lung cancer.

Cheng Y, Liu XQ, Fan Y, Liu YP, Liu Y, Liu Y, Ma LX, Liu XH, Li H, Bao HZ, Liu JJ, Zhang S, Wu CJ. Cheng Y, et al. Future Oncol. 2016 Mar;12(6):789-99. doi: 10.2217/fon.15.346. Epub 2016 Feb 3. Future Oncol. 2016. PMID: 26838372 Clinical Trial.

7

[Distribution and Clinical Significance of CTLA-4, PD-1 and PD-L1 in Peripheral Blood of Patients with Small Cell Lung Cancer].

Li H, Liu Y, Liu Y, Liu J, Zhao D, Wang Y, Cheng Y. Li H, et al. Among authors: liu j, liu y. Zhongguo Fei Ai Za Zhi. 2017 Nov 20;20(11):755-760. doi: 10.3779/j.issn.1009-3419.2017.11.06. Zhongguo Fei Ai Za Zhi. 2017. PMID: 29167005 Free PMC article. Chinese.

8

[Research Progress of Immunotherapy for Brain Metastases in Patients  with Drive Gene Negative NSCLC].

Zhang S, Liu J, Yang C, Li S, Cheng Y. Zhang S, et al. Among authors: liu j. Zhongguo Fei Ai Za Zhi. 2018 Aug 20;21(8):610-614. doi: 10.3779/j.issn.1009-3419.2018.08.06. Zhongguo Fei Ai Za Zhi. 2018. PMID: 30172268 Free PMC article. Review. Chinese.

9

Chemotherapy combined with bevacizumab for the treatment of advanced lung adenocarcinoma cancer harboring EGFR-ANXA2, EGFR-RAD51, ATR and BRCA2 mutations: A case report.

Zhong R, Li H, Liu Y, Zhang S, Liu J, Huang Z, Cheng Y. Zhong R, et al. Among authors: liu j, liu y. Thorac Cancer. 2020 Feb;11(2):456-460. doi: 10.1111/1759-7714.13286. Epub 2019 Dec 22. Thorac Cancer. 2020. PMID: 31865638 Free PMC article.

10

[Highlights of PAPR Inhibitors in Small Cell Lung Cancer].

Zhang S, Liu J, Yang C, Zhang L, Li S, Bao H, Cheng Y. Zhang S, et al. Among authors: liu j. Zhongguo Fei Ai Za Zhi. 2020 Sep 20;23(9):806-810. doi: 10.3779/j.issn.1009-3419.2020.102.19. Epub 2020 Aug 5. Zhongguo Fei Ai Za Zhi. 2020. PMID: 32752582 Free PMC article. Review. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

147,206 results

Search Page

Filters